- Home
- VMAR vs ONCO Comparison
VMAR vs ONCO Comparison
Compare VMAR & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- ONCO
- Stock Information
- Founded
- VMAR 1995
- ONCO 2018
- Country
- VMAR Canada
- ONCO United States
- Employees
- VMAR N/A
- ONCO N/A
- Industry
- VMAR Marine Transportation
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- ONCO Health Care
- Exchange
- VMAR Nasdaq
- ONCO Nasdaq
- Market Cap
- VMAR 4.5M
- ONCO 4.3M
- IPO Year
- VMAR 2020
- ONCO 2022
- Fundamental
- Price
- VMAR $1.24
- ONCO $2.17
- Analyst Decision
- VMAR
- ONCO
- Analyst Count
- VMAR 0
- ONCO 0
- Target Price
- VMAR N/A
- ONCO N/A
- AVG Volume (30 Days)
- VMAR 252.7K
- ONCO 30.7K
- Earning Date
- VMAR 01-12-2026
- ONCO 11-13-2025
- Dividend Yield
- VMAR N/A
- ONCO N/A
- EPS Growth
- VMAR N/A
- ONCO N/A
- EPS
- VMAR N/A
- ONCO N/A
- Revenue
- VMAR $1,128,568.00
- ONCO $1,223,751.00
- Revenue This Year
- VMAR N/A
- ONCO N/A
- Revenue Next Year
- VMAR $264.29
- ONCO N/A
- P/E Ratio
- VMAR N/A
- ONCO N/A
- Revenue Growth
- VMAR N/A
- ONCO N/A
- 52 Week Low
- VMAR $1.10
- ONCO $2.10
- 52 Week High
- VMAR $39.00
- ONCO $179.35
- Technical
- Relative Strength Index (RSI)
- VMAR 43.80
- ONCO 38.17
- Support Level
- VMAR $1.10
- ONCO $2.17
- Resistance Level
- VMAR $1.58
- ONCO $2.35
- Average True Range (ATR)
- VMAR 0.10
- ONCO 0.20
- MACD
- VMAR 0.00
- ONCO -0.02
- Stochastic Oscillator
- VMAR 29.52
- ONCO 29.91
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.